STAT Plus: Kymera announces $102 million in new funding to develop treatments for diseases such as blood cancers
Kymera Therapeutics said Thursday has now raised more than a quarter-billion dollars to treat a range of diseases, including blood cancers.
No hay comentarios:
Publicar un comentario